Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Konrad Zuzda, Wiktoria Grycuk, Jacek Małyszko & Jolanta Małyszko. (2022) Kidney and lipids: novel potential therapeutic targets for dyslipidemia in kidney disease?. Expert Opinion on Therapeutic Targets 26:11, pages 995-1009.
Read now
Read now
Etienne Khoury, Diane Brisson, Nathalie Roy, Gérald Tremblay & Daniel Gaudet. (2019) Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemia. Expert Opinion on Drug Safety 18:5, pages 403-414.
Read now
Read now
Lane B. Benes, Eric J. Brandt & Michael H. Davidson. (2018) Advances in diagnosis and potential therapeutic options for familial chylomicronemia syndrome. Expert Opinion on Orphan Drugs 6:2, pages 141-149.
Read now
Read now
Jooho Lee & Robert A. Hegele. (2017) Investigated treatments for lipoprotein lipase deficiency and related metabolic disorders. Expert Opinion on Orphan Drugs 5:5, pages 411-420.
Read now
Read now
Articles from other publishers (21)
György Paragh, Ákos Németh, Mariann Harangi, Maciej Banach & Péter Fülöp. (2022) Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia. Lipids in Health and Disease 21:1.
Crossref
Crossref
Saverio Muscoli, Mihaela Ifrim, Massimo Russo, Francesco Candido, Angela Sanseviero, Marialucia Milite, Marco Di Luozzo, Massimo Marchei & Giuseppe Massimo Sangiorgi. (2022) Current Options and Future Perspectives in the Treatment of Dyslipidemia. Journal of Clinical Medicine 11:16, pages 4716.
Crossref
Crossref
Boah Lee, Seung Ju Park, Seulgi Lee, Jinwook Lee, Eunbeol Lee, Eun-Seon Yoo, Won-Suk Chung, Jong-Woo Sohn, Byung-Chul Oh & Seyun Kim. (2022) Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR. Cell Death & Disease 13:7.
Crossref
Crossref
Dorota Formanowicz, Marcin Radom, Agnieszka Rybarczyk, Krzysztof Tanaś & Piotr Formanowicz. (2022) Control of Cholesterol Metabolism Using a Systems Approach. Biology 11:3, pages 430.
Crossref
Crossref
Laura D’Erasmo, Antonio Gallo, Angelo Baldassare Cefalù, Alessia Di Costanzo, Samir Saheb, Antonina Giammanco, Maurizio Averna, Alessio Buonaiuto, Gabriella Iannuzzo, Giuliana Fortunato, Arturo Puja, Tiziana Montalcini, Chiara Pavanello, Laura Calabresi, Giovanni Battista Vigna, Marco Bucci, Katia Bonomo, Fabio Nota, Tiziana Sampietro, Francesco Sbrana, Patrizia Suppressa, Carlo Sabbà, Fabio Fimiani, Arturo Cesaro, Paolo Calabrò, Silvia Palmisano, Sergio D’Addato, Livia Pisciotta, Stefano Bertolini, Randa Bittar, Olga Kalmykova, Sophie Béliard, Alain Carrié, Marcello Arca & Eric Bruckert. (2021) Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Abudukadier Abulizi, Daniel F. Vatner, Zhang Ye, Yongliang Wang, Joao-Paulo Camporez, Dongyan Zhang, Mario Kahn, Kun Lyu, Alaa Sirwi, Gary W. Cline, M. Mahmood Hussain, Patricia Aspichueta, Varman T. Samuel & Gerald I. Shulman. (2020) Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice. Journal of Lipid Research 61:12, pages 1565-1576.
Crossref
Crossref
Chandramukhi Sunehra & Krishnaswamy Raghu. (2020) Familial Hypercholesterolaemia With Premature Coronary Artery Disease: A Case Report. Indian Journal of Clinical Cardiology 1:3-4, pages 150-153.
Crossref
Crossref
Álvaro J. Ruiz, Luisa Fernanda Patiño, Kelly Amaya, Juan Esteban Gómez, Felipe Ordóñez, Samuel Paternina, Misael Mercado, Harry Pachajoa, Rafael Campo, Gustavo Giraldo, Ravagly Jiménez, Nohora Zuluaga, Jeniffer Monroy, Julián Gil-Forero, Audrey Matallana, Carolina Rivera, Mauricio Coll, William A. Peña-Vargas, Octavio Manjarrez, Juan Martín Toro, Álvaro Barrera, Diego Hoyos & Harold García. (2020) Hipercolesterolemia familiar: serie de 36 casos con fenotipo de hipercolesterolemia familiar homocigótica. Revista Colombiana de Cardiología 27:6, pages 498-507.
Crossref
Crossref
S. Udhaya Kumar, D. Thirumal Kumar, R. Bithia, Srivarshini Sankar, R. Magesh, Mariem Sidenna, C. George Priya Doss & Hatem Zayed. (2020) Analysis of Differentially Expressed Genes and Molecular Pathways in Familial Hypercholesterolemia Involved in Atherosclerosis: A Systematic and Bioinformatics Approach. Frontiers in Genetics 11.
Crossref
Crossref
Antonina Giammanco, Angelo B. Cefalù, Davide Noto & Maurizio R. Averna. (2020) Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide. Current Medicinal Chemistry 27:23, pages 3773-3783.
Crossref
Crossref
Yanhong Luo, Min Zheng, Yutin Zhang, Shuang He, Lei Zhang, Huichao Sun, Xiaoyan Liu, Tao Tan, Hua Zhu & Jianfeng He. (2019) Familial hypercholesterolemia with early coronary atherosclerotic heart disease: A case report. Experimental and Therapeutic Medicine.
Crossref
Crossref
Charles J. Ferro, Patrick B. Mark, Mehmet Kanbay, Pantelis Sarafidis, Gunnar H. Heine, Patrick Rossignol, Ziad A. Massy, Francesca Mallamaci, Jose M. Valdivielso, Jolanta Malyszko, Marianne C. Verhaar, Robert Ekart, Raymond Vanholder, Gerard London, Alberto Ortiz & Carmine Zoccali. (2018) Lipid management in patients with chronic kidney disease. Nature Reviews Nephrology 14:12, pages 727-749.
Crossref
Crossref
Marzieh Nikkhooy, Ali Mohammad Foroughmand, Hamid Galehdari & Saeed Yazdankhah. (2018) The First Report of GAC>AAC Mutation in Familial Hypercholesterolemia in Khuzestan. Zahedan Journal of Research in Medical Sciences 20:8.
Crossref
Crossref
Simona Sperlongano, Felice Gragnano, Francesco Natale, Laura D’Erasmo, Claudia Concilio, Arturo Cesaro, Enrica Golia, Mario Crisci, Rossella Sperlongano, Fabio Fimiani, Mariagiovanna Russo, Marcello Arca, Giuseppe Limongelli & Paolo Calabrò. (2018) Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience. Journal of Cardiovascular Medicine 19:3, pages 83-90.
Crossref
Crossref
Brittany Taylor, Adnan Cheema & Louis Soslowsky. (2017) Tendon Pathology in Hypercholesterolemia and Familial Hypercholesterolemia. Current Rheumatology Reports 19:12.
Crossref
Crossref
Nasreen Al Sayed, Khalid Al Waili, Fatheya Alawadi, Saeed Al-Ghamdi, Wael Al Mahmeed, Fahad Al-Nouri, Mona Al Rukhaimi, Khalid Al-Rasadi, Zuhier Awan, Mohamed Farghaly, Mohamed Hassanein, Hani Sabbour, Mohammad Zubaid & Philip Barter. (2016) Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East. International Journal of Cardiology 225, pages 268-283.
Crossref
Crossref
Alonso Merchán, Álvaro J. Ruiz, Rafael Campo, Carlos E. Prada, Juan M. Toro, Robinson Sánchez, Juan E. Gómez, Nicolás I. Jaramillo, Dora I. Molina, Hernando Vargas-Uricoechea, Sherien Sixto, Javier M. Castro, Adalberto E. Quintero, Mauricio Coll, Stase Slotkus, Andrés Ramírez, Harry Pachajoa, Fernando A. Ávila & Rodrigo Alonso K. (2016) Hipercolesterolemia familiar: artículo de revisión. Revista Colombiana de Cardiología 23, pages 4-26.
Crossref
Crossref
V. N. Titov. (2016) ARTICLE RETRACTED: THE ALCOHOL CHOLESTEROL, ITS BIOLOGICAL ROLE DURING PHYLOGENESIS, MECHANISMS OF STEROL PRODUCTION BY STATINS, PHARMACOGENOMIC FACTORS AND DIAGNOSTIC VALIDIDTY OF LOW DENSITY LIPOPROTEIN CHOLESTEROL. Eurasian heart journal:1, pages 56-66.
Crossref
Crossref
Dirk J. Blom, Zahi A. Fayad, John J.P. Kastelein, Dominique Larrey, Lukas Makris, Charles Schwamlein, LeAnne Bloeden & James Underberg. (2016) LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design. Journal of Clinical Lipidology 10:2, pages 273-282.
Crossref
Crossref
Amanda J. Brahm & Robert A. Hegele. (2015) Chylomicronaemia—current diagnosis and future therapies. Nature Reviews Endocrinology 11:6, pages 352-362.
Crossref
Crossref
Claudia Stefanutti & Gilbert R. Thompson. (2014) Lipoprotein Apheresis in the Management of Familial Hypercholesterolaemia: Historical Perspective and Recent Advances. Current Atherosclerosis Reports 17:1.
Crossref
Crossref